erdafitinib (Balversa) Report issue

Small molecule Approved FDA Accelerated Approval FDA Priority Review FDA
AACT ChEMBL DrugBank PubChem
Back

Drug Pricing Summary

VA Big4

$202.1064 - $336.8443

VA FSS

$202.1064 - $336.8443

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
erdafitinib 3 mg (TABLET) $202.1064 VA Big4
  • BALVERSA (84)
    		•  J & J Health Care Systems on behalf of Janssen Biotech Inc.
    erdafitinib 3 mg (TABLET) $202.1064 VA FSS
  • BALVERSA (84)
    		•  J & J Health Care Systems on behalf of Janssen Biotech Inc.
    erdafitinib 3 mg (TABLET) $202.1066 VA Big4
  • BALVERSA (56)
    		•  J & J Health Care Systems on behalf of Janssen Biotech Inc.
    erdafitinib 3 mg (TABLET) $202.1066 VA FSS
  • BALVERSA (56)
    		•  J & J Health Care Systems on behalf of Janssen Biotech Inc.
    erdafitinib 4 mg (TABLET) $269.4754 VA Big4
  • BALVERSA (28)
    		•  J & J Health Care Systems on behalf of Janssen Biotech Inc.
  • BALVERSA (56)
    		•  J & J Health Care Systems on behalf of Janssen Biotech Inc.
    erdafitinib 4 mg (TABLET) $269.4754 VA FSS
  • BALVERSA (28)
    		•  J & J Health Care Systems on behalf of Janssen Biotech Inc.
  • BALVERSA (56)
    		•  J & J Health Care Systems on behalf of Janssen Biotech Inc.
    erdafitinib 5 mg (TABLET) $336.8443 VA Big4
  • BALVERSA (28)
    		•  J & J Health Care Systems on behalf of Janssen Biotech Inc.
    erdafitinib 5 mg (TABLET) $336.8443 VA FSS
  • BALVERSA (28)
    		•  J & J Health Care Systems on behalf of Janssen Biotech Inc.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue